New ASE Guideline Aims to Optimize Care for Pediatric Oncology Patients


Contact: Angie Porter

New Guideline Aims to Optimize Care for Pediatric Oncology Patients

The guideline focuses on the use of echocardiography and multimodality imaging in monitoring cardiac function in children with cancer

(DURHAM, NC, December 4, 2023)—A new guideline from the American Society of Echocardiography (ASE) offers recommendations to pediatric cardiologists and oncologists on the application of multimodality imaging in children undergoing cancer treatment.

Cardiovascular ultrasound has long been recognized as a valuable tool in assessing cardiac function and is the first-line imaging technique used to monitor cardiac function during and after cancer treatment in both adult and pediatric patients. However, as the field of pediatric cardio-oncology continues to evolve, children with cancer may also benefit from the addition of other noninvasive imaging techniques.

The newly released guideline, titled “Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: Recommendations From the American Society of Echocardiography,” provides detailed guidance on how to perform echocardiographic exams, which parameters to use in clinical decision making, and the circumstances under which additional imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography (CT), should be considered.

“Cardiovascular complications developing during and after cancer treatment remain a significant challenge and continue to compromise the long-term health of this growing patient cohort,” says Luc Mertens, MD, PhD, FASE, chair of the guideline writing group. “The primary goal of cardiac monitoring is to identify early signs of potentially reversible heart disease and to minimize the risk of progression from asymptomatic to clinically overt heart disease.”

The document also stresses that therapeutic decisions should be based on multidisciplinary discussions among cardiologists, oncology teams, and the patient and their family.

“This guideline highlights the knowledge gaps in the current practice of cardiac monitoring and cautions making therapeutic decisions on cancer treatment for pediatric patients solely on cardiac imaging data,” says Gautam Singh, MD, FASE, co-chair of the writing group. “By standardizing the use of echocardiography and providing evidence-based recommendations, this guideline can help improve long-term cardiac outcomes of pediatric cancer patients.”

This document is published in the December 2023 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website or social media pages on Facebook, Twitter, LinkedIn, or Instagram.



Share via
Copy link
Powered by Social Snap